A Study of PM8002 Injection in Combination With Standard Chemotherapy as First Line Therapy in MPM
Clinical trial NCT05918107 · COMPLETED
Trial details
- NCT number
- NCT05918107
- Sponsor
- Biotheus Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-13
- Primary completion
- 2026-03-31
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.